Total Payments
$17,870
2024 Payments
$1,658
Companies
67
Transactions
1,064
Medicare Patients
11,911
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$17,847 (99.9%)
Education$23.20 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,847 | 1,062 | 99.9% |
| Education | $23.20 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,763 | 173 | $0 (2024) |
| Amgen Inc. | $2,743 | 114 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,945 | 100 | $0 (2024) |
| PFIZER INC. | $1,070 | 68 | $0 (2024) |
| ABBVIE INC. | $1,054 | 79 | $0 (2024) |
| Lilly USA, LLC | $772.09 | 60 | $0 (2024) |
| GlaxoSmithKline, LLC. | $616.93 | 36 | $0 (2024) |
| Amarin Pharma Inc. | $524.27 | 38 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $484.67 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $466.21 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,658 | 89 | Novo Nordisk Inc ($258.07) |
| 2023 | $2,488 | 161 | Novo Nordisk Inc ($354.40) |
| 2022 | $2,379 | 161 | Novo Nordisk Inc ($311.27) |
| 2021 | $3,014 | 174 | AstraZeneca Pharmaceuticals LP ($609.04) |
| 2020 | $1,763 | 107 | Amgen Inc. ($415.04) |
| 2019 | $1,645 | 107 | Amgen Inc. ($456.73) |
| 2018 | $2,118 | 107 | Amgen Inc. ($593.05) |
| 2017 | $2,805 | 158 | Novo Nordisk Inc ($544.68) |
All Payment Transactions
1,064 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $58.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.59 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Obesity | ||||||
| 11/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $27.00 | General |
| 10/24/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Bone Health | ||||||
| 10/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $16.90 | General |
| 10/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.73 | General |
| 10/01/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $21.84 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,668 | 4,728 | $814,913 | $262,215 |
| 2022 | 21 | 2,532 | 6,152 | $911,460 | $297,082 |
| 2021 | 24 | 2,700 | 7,167 | $992,845 | $336,575 |
| 2020 | 33 | 4,011 | 7,816 | $1.0M | $346,753 |
Total Patients
11,911
Total Services
25,863
Medicare Billing
$1.2M
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 595 | 1,482 | $383,838 | $115,227 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 437 | 960 | $165,120 | $50,380 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 385 | 385 | $100,485 | $46,898 | 46.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 102 | 139 | $48,650 | $15,946 | 32.8% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 158 | 159 | $11,448 | $5,245 | 45.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 160 | 160 | $8,320 | $4,638 | 55.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 91 | 148 | $8,880 | $3,589 | 40.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 54 | 90 | $6,750 | $3,247 | 48.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $15,522 | $3,129 | 20.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 113 | 323 | $22,774 | $2,817 | 12.4% |
| 99291 | Critical care, first 30-74 minutes | Office | 2023 | 12 | 13 | $12,662 | $2,369 | 18.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 27 | 29 | $2,581 | $1,176 | 45.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 69 | $3,864 | $1,042 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $4,940 | $929.09 | 18.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 29 | 54 | $1,836 | $861.80 | 46.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 18 | $2,214 | $848.88 | 38.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 48 | 48 | $1,968 | $830.88 | 42.2% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 23 | 24 | $4,140 | $786.72 | 19.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 81 | 85 | $3,145 | $722.99 | 23.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 70 | 94 | $2,444 | $713.18 | 29.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 111 | 163 | $1,304 | $354.20 | 27.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $700.00 | $242.34 | 34.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 13 | 17 | $238.00 | $88.97 | 37.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 15 | 15 | $150.00 | $64.35 | 42.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 31 | 134 | $268.00 | $45.61 | 17.0% |
About Dr. Quentin Mewborn, MD
Dr. Quentin Mewborn, MD is a Family Medicine healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831240308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Quentin Mewborn, MD has received a total of $17,870 in payments from pharmaceutical and medical device companies, with $1,658 received in 2024. These payments were reported across 1,064 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($17,847).
As a Medicare-enrolled provider, Mewborn has provided services to 11,911 Medicare beneficiaries, totaling 25,863 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Greenville, NC
- Active Since 01/13/2007
- Last Updated 01/31/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1831240308
Products in Payments
- FARXIGA (Drug) $722.01
- Ozempic (Drug) $669.65
- EVENITY (Biological) $604.64
- Repatha (Biological) $598.87
- Saxenda (Drug) $579.32
- Aimovig (Biological) $578.86
- Prolia (Biological) $546.91
- Wegovy (Drug) $530.27
- Vascepa (Drug) $524.27
- Otezla (Drug) $414.18
- XARELTO (Drug) $368.47
- NURTEC ODT (Drug) $359.61
- BREZTRI (Drug) $346.58
- JARDIANCE (Drug) $341.69
- LEQVIO (Drug) $322.11
- UBRELVY (Drug) $317.60
- SYMBICORT (Drug) $308.47
- Livalo (Drug) $301.41
- TRELEGY ELLIPTA (Drug) $294.57
- Auvelity (Drug) $275.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greenville
James Franklin, M.d, M.D
Family Medicine — Payments: $114,754
Family Medicine $114,754
Jeffrey Harris, Md, MD
Family Medicine — Payments: $112,265
Family Medicine $112,265
Steve Hamberis, M.d, M.D
Family Medicine — Payments: $23,679
Family Medicine $23,679
Dr. Richard Leland, M.d, M.D
Family Medicine — Payments: $22,628
Family Medicine $22,628
Eric Faile, M.d, M.D
Family Medicine — Payments: $17,596
Family Medicine $17,596
Saria Saccocio, Md, MD
Family Medicine — Payments: $17,308
Family Medicine $17,308